Shaping the future of digestive health in Europe and beyond.
United European Gastroenterology
Loading...
Thank you to everyone who joined us in Vienna for the joint meeting of National Societies Forum & Meeting of Members!
From interactive workshop sessions to strategic exchanges โ your engagement & insights are what drive the UEG community forward.
Until next time!
๐ #weareUEG
๐งฌ Genetic testing does NOT replace surveillance in #PancreaticCancer
Prospective study (n=500)
๐ธ Pathogenic variants in 8.8%; 3.4% high-penetrance
๐ธ ~50% carriers missed by current criteria
๐ธ Cancer can occur without mutations
Learn more in UEG Journal:
๐ https://bit.ly/4duoufq
In part 2 of our MASLD series, Sven Francque outlines that resmetirom is now approved in F2-F3 fibrosis in parts of Europe, semaglutide has produced positive phase 3 data in MASH, and the guideline is being updated.
Tune in now:
๐ https://bit.ly/44R97K3
Weโve explored how much of this burden is preventable โ from the role of nutrition and ultra-processed foods ๐ฝ๏ธ to the life-saving potential of early detection through screening ๐ฉบ
This #DigestiveHealthMonth, weโve taken a closer look at one of Europeโs most pressing public health challenges โ the growing burden of digestive diseases and cancers ๐ โ and what the evidence tells us about how to respond ๐
On #WDHD2026, listen to our recent policy webinar exploring whether the EU Safe Hearts Plan can improve digestive health โ and the changes needed to drive progress on prevention.
Watch the full discussion on YouTube: https://bit.ly/3Rb2vTx or Gutflix: https://bit.ly/4fn17Hi